Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432562
Status:
COMPLETED
Last Update Posted:
2012-02-23
First Post:
2007-02-06
Brief Title:
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer
Sponsor:
Mast Therapeutics Inc
Organization:
Mast Therapeutics Inc
Organization Data
Organization:
Mast Therapeutics Inc
Class:
INDUSTRY
Study ID:
530-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mast Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Chief Executive Officer
Old Organization:
Adventrx Pharmaceuticals Inc
Collaborators
| Name | Class |
|---|---|
| Worldwide Clinical Trials | OTHER |
| Synteract Inc | INDUSTRY |
| Thywill Latam Solutions SRL | UNKNOWN |
| OCASA Soluciones Logísticas SA | UNKNOWN |